PHAGESTI® (4 x 20 ml)

PHAGESTI® (4 x 20 ml)
Product Description

Therapeutic indications PHAGESTI® is used for diseases caused by bacteria (Shigella, Salmonella, E.сoli, Proteus, Staphylococcus, Pseudomonas, Enterococcus) or their combination: Shigellosis, salmonellosis, typhoid, paratyphoid, irritable bowel syndrome (dysbacteriosis), enterocolitis, infectious colitis, dyspepsia in complex therapy. for the treatment and prevention of foodborne infection and other bacterial diarrhea (diarrhoea); Also in case of gastrointestinal discomfort, in all age and high risk groups of patients. Contraindications: Hypersensitivity to any component of the contents of the drug vial. Special warnings: There are no special precautions when using the drug. In case of using a volume of less than 20 ml, it is recommended to remove the drug with a sterile syringe. The integrity of the contents of the broken vial is allowed to be used within 24 hours after opening if the storage conditions are fully observed. It is not allowed to take the drug in a confused state! Keep out of reach of children! Interaction with other medicinal products: The incompatibility of the drug with other medicinal products has not been established. It can be used in complex treatment together with other herbal remedies, including antibacterial drugs (antibiotics). Pregnancy and lactation: The drug can be used during pregnancy and lactation. Effects on the ability to drive and use machines: Taking the drug does not affect the ability to drive and use machines. Dosage, method of use and method of administration: One of the important prerequisites for the effectiveness of phage therapy is to determine the sensitivity of the disease-causing microorganism to the phage (the phages contained in the drug). The drug is especially effective when used in the early stages of the disease.

JSC Biochimpharm

  • Country/Region:
    Georgia
  • Founded:
    1999
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    50 - 99
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical

JSC Biochimpharm

  • Country/Region:
    Georgia
  • Founded:
    1999
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    50 - 99
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical

More Products from JSC Biochimpharm (4)

  • Phagyo® (4 x 20 ml)

    Product Phagyo® (4 x 20 ml)

    PHAGYO used for treatment and prophylaxis of bacterial purulent–inflammatory infections, caused by the following microorganisms – Streptococcus, Staphylococcus, E.Coli, Pseudomonas aeruginosa, Proteus and their combinations. Bacterial infections of the upper and lower respiratory tract (Inflammation of th...
  • Phagestaph® (4 x 20 ml)

    Product Phagestaph® (4 x 20 ml)

    Phagestaph® (4 x 20 ml) Therapeutic Indications: Preparation is used for the treatment and prophylaxis of bacterial purulent–inflammatory infections, caused by Staphylococcus aureus in all age and high risk groups: Surgery: purulent wound, burns, abscess, phlegmon, furuncles, carbuncles, hidradenitis, p...
  • Phagyo® spray (20 ml)

    Product Phagyo® spray (20 ml)

    Therapeutical indications: Phagyo spray is used for treatment and prophylaxis of the purulent diseases caused by bacterias Streptococcus, Staphylococcus, E.Coli, Pseudomonas aeruginosa, Proteus in patients of all age and high risk groups. The medication is used for: the treatement of pharyngitis, laryngi...
  • PowerPhage®

    Product PowerPhage®

    The world’s first natural antimicrobial veterinary solution against Salmonella, E. coli, Shigella and other pathogenic (harmful) bacteria bankrupting the poultry and livestock industry. An innovative feed additive, PowerPhage™ eliminates even antibiotic resistant Salmonella and other pathogenic bacteri...

JSC Biochimpharm resources (1)